Search Results - "Webb, Penelope"

Epidemiology of epithelial ovarian cancer by Webb, Penelope M, Jordan, Susan J

“…Globally, ovarian cancer is the seventh most common cancer in women and the eighth most common cause of cancer death, with five-year survival rates below 45%…”
Get full text

Global epidemiology of epithelial ovarian cancer by Webb, Penelope M., Jordan, Susan J.

“…Globally, ovarian cancer is the eighth most common cancer in women, accounting for an estimated 3.7% of cases and 4.7% of cancer deaths in 2020. Until the…”
Get full text

BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group by ALSOP, Kathryn, FEREDAY, Sian, FRIEDLANDER, Michael, FOX, Stephen, BOWTELL, David, MITCHELL, Gillian, MELDRUM, Cliff, DEFAZIO, Anna, EMMANUEL, Catherine, GEORGE, Joshy, DOBROVIC, Alexander, BIRRER, Michael J, WEBB, Penelope M, STEWART, Colin

“…The frequency of BRCA1 and BRCA2 germ-line mutations in women with ovarian cancer is unclear; reports vary from 3% to 27%. The impact of germ-line mutation on…”
Get full text

A systematic literature review of the prevalence of and risk factors for supportive care needs among women with gynaecological cancer and their caregivers by Beesley, Vanessa L., Alemayehu, Chalachew, Webb, Penelope M.

“…Purpose This review aimed to determine the prevalence of met and unmet needs, and the risk factors for unmet needs among people affected by gynaecological…”
Get full text

Statin use and survival following a diagnosis of ovarian cancer: A prospective observational study by Majidi, Azam, Na, Renhua, Jordan, Susan J., De Fazio, Anna, Webb, Penelope M.

“…Most women with ovarian cancer have a poor prognosis, but studies have reported an association between statin use and improved survival. We investigated the…”
Get full text

Does aspirin have a role in management of ovarian cancer? by Webb, Penelope M

“…While low-dose aspirin is commonly used to prevent cardiovascular disease, its use in oncology is less accepted, although the US Preventive Services Task Force…”
Get full text

Common medications and survival in women with ovarian cancer: A systematic review and meta-analysis by Majidi, Azam, Na, Renhua, Dixon-Suen, Suzanne, Jordan, Susan J., Webb, Penelope M.

“…Ovarian cancer is usually diagnosed at an advanced stage when five-year relative survival is <50%. Therefore, strategies to improve survival are required…”
Get full text

Health services costs for ovarian cancer in Australia: Estimates from the 45 and Up Study by Goldsbury, David E, Vassallo, Amy, Weber, Marianne F, Steinberg, Julia, Webb, Penelope M, DeFazio, Anna, Canfell, Karen

“…There have been significant advancements in risk identification and treatment for ovarian cancer over the last decade. However, their impact on health services…”
Get full text

Vitamin D status during and after treatment and ovarian cancer survival by Ross, Tanya L., Neale, Rachel E., Na, Renhua, Webb, Penelope M.

“…Purpose Five-year relative survival for ovarian cancer remains below 50%. Strategies to improve outcomes are needed. Higher serum 25-hydroxyvitamin D [25(OH)D]…”
Get full text

The influence of birth cohort and calendar period on global trends in ovarian cancer incidence by Cabasag, Citadel J., Arnold, Melina, Butler, John, Inoue, Manami, Trabert, Britton, Webb, Penelope M, Bray, Freddie, Soerjomataram, Isabelle

“…Ovarian cancer is the eighth most common cancer in women worldwide and incidence rates vary markedly by world region. Our study provides a comprehensive…”
Get full text

Impact of disease recurrence on the supportive care needs of patients with ovarian cancer and their caregivers by DiSipio, Tracey, Hartel, Gunter, Butow, Phyllis, Webb, Penelope M., Beesley, Vanessa L.

“…We aimed to explore the supportive care needs of ovarian cancer patients and their caregivers before and after the first cancer recurrence, the top unmet needs…”
Get full text

A systematic literature review of trials of survivorship interventions for women with gynaecological cancer and their caregivers by Beesley, Vanessa L., Alemayehu, Chalachew, Webb, Penelope M.

“…Core components of survivorship care include treatment of late and long‐term effects, care coordination, promotion of psychological well‐being, health and…”
Get full text

Use of menopausal hormone therapy before and after diagnosis and ovarian cancer survival-A prospective cohort study in Australia by Na, Renhua, Jordan, Susan J, DeFazio, Anna, Williams, Merran, Livingstone, Karen, Obermair, Andreas, Friedlander, Michael, Grant, Peter, Webb, Penelope M

“…Menopausal hormone therapy (MHT) use before ovarian cancer diagnosis has been associated with improved survival but whether the association varies by type and…”
Get full text

Statin use and survival among women with ovarian cancer: an Australian national data-linkage study by Feng, Jia-Li, Dixon-Suen, Suzanne C., Jordan, Susan J., Webb, Penelope M.

“…Background Five-year ovarian cancer survival rates are below 50%; there is considerable interest in whether common medications like statins may improve…”
Get full text

Common analgesics and ovarian cancer survival: the Ovarian cancer Prognosis And Lifestyle (OPAL) Study by Majidi, Azam, Na, Renhua, Jordan, Susan J, DeFazio, Anna, Obermair, Andreas, Friedlander, Michael, Grant, Peter, Webb, Penelope M

“…Abstract Background Most women with ovarian cancer (OC) are diagnosed with advanced disease. They often experience recurrence after primary treatment, and…”
Get full text

How many cancer cases and deaths are potentially preventable? Estimates for Australia in 2013 by Wilson, Louise F., Antonsson, Annika, Green, Adele C., Jordan, Susan J., Kendall, Bradley J., Nagle, Christina M., Neale, Rachel E., Olsen, Catherine M., Webb, Penelope M., Whiteman, David C.

“…Cancer is a leading cause of disease burden in Australia, particularly fatal burden, accounting for an estimated thirty percent of deaths. Many cancers develop…”
Get full text

The D-Health Trial: a randomised controlled trial of the effect of vitamin D on mortality by Neale, Rachel E, Baxter, Catherine, Romero, Briony Duarte, McLeod, Donald S A, English, Dallas R, Armstrong, Bruce K, Ebeling, Peter R, Hartel, Gunter, Kimlin, Michael G, O'Connell, Rachel, van der Pols, Jolieke C, Venn, Alison J, Webb, Penelope M, Whiteman, David C, Waterhouse, Mary

“…The effect of supplementing unscreened adults with vitamin D3 on mortality is unclear. We aimed to determine whether monthly doses of vitamin D3 influenced…”
Get full text

When will I feel normal again? Trajectories and predictors of persistent symptoms and poor wellbeing after primary chemotherapy for ovarian cancer by Beesley, Vanessa L., Webber, Kate, Nagle, Christina M., DeFazio, Anna, Obermair, Andreas, Williams, Merran, Friedlander, Michael, Webb, Penelope M.

“…After treatment for ovarian cancer, women want to know when they will feel ‘normal’ again. Our objective was to document the proportions of women with high…”
Get full text

Obesity and ovarian cancer survival: a systematic review and meta-analysis by Protani, Melinda M, Nagle, Christina M, Webb, Penelope M

“…Studies that have examined the association between obesity and ovarian cancer survival have provided conflicting results. We reviewed and quantitatively…”
Get full text

Environmental (nongenetic) factors in gynecological cancers: update and future perspectives by Webb, Penelope M

“…Globally, gynecological cancers comprise three of the seven most common female cancers and are responsible for more than 1,000,000 new cases and 500,000 deaths…”
Get full text